|
|
||||||||
lb500 |
Microbiology and Immunology, University of Montreal, Montreal, Canada
ABSTRACT
Interleukin-21 (IL-21) is a relatively recently discovered type-1 cytokine. It is a CD4+ T cell-derived cytokine and has pleiotropic effects on the functions of immune cells. The cytokine bears special relevance to HIV infection as it is mainly produced by CD4+ T cells: the main targets of the virus. Therefore, we were interested in knowing how this cytokine is regulated in vivo in this viral infection. For this purpose, we measured IL-21 by ELISA in the sera of 29 AIDS patients and compared them with a similar number of sera from age-matched HIV-seronegative healthy persons.
Our data show that the sera from HIV-infected patients had 2 fold less concentrations of IL-21 as compared to the healthy subjects. Levels of circulating IL-21 depended upon the quantity of CD4+ T cells present in the circulation of the patients. Thus, the patients with low numbers of CD4+ T cell counts showed lower levels of this cytokine as compared to the patients with higher CD4+ T cell counts. Indeed, a significant positive correlation existed between the numbers of CD4+ T cells and the levels of IL-21 in sera from AIDS patients.
To conclude, the depletion of CD4+ T cells during HIV infection results in low levels of circulating IL-21 in HIV-infected patients. The positive correlation between numbers of CD4+ T cells and concentrations of IL-21 may suggest the use of this cytokine as a reliable hallmark for the progression of HIV-induced AIDS.
| ||||||||||||||||||||||||||||||||||||||||||||